Amniotics AB (publ) (AMNI.ST)

SEK 0.01

(5.88%)

Total Debt Summary of Amniotics AB (publ)

  • Amniotics AB (publ)'s latest annual total debt in 2023 was 2.58 Million SEK , down -82.88% from previous year.
  • Amniotics AB (publ)'s latest quarterly total debt in 2023 FY was 2.58 Million SEK , down -82.88% from previous quarter.
  • Amniotics AB (publ) reported annual total debt of 15.06 Million SEK in 2022, up 1958.33% from previous year.
  • Amniotics AB (publ) reported annual total debt of 732 Thousand SEK in 2021, down -49.37% from previous year.
  • Amniotics AB (publ) reported quarterly total debt of - SEK for 2023 Q3, down 0.0% from previous quarter.
  • Amniotics AB (publ) reported quarterly total debt of - SEK for 2023 Q1, down -100.0% from previous quarter.

Annual Total Debt Chart of Amniotics AB (publ) (2023 - 2018)

Historical Annual Total Debt of Amniotics AB (publ) (2023 - 2018)

Year Total Debt Total Debt Growth
2023 2.58 Million SEK -82.88%
2022 15.06 Million SEK 1958.33%
2021 732 Thousand SEK -49.37%
2020 1.44 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%

Peer Total Debt Comparison of Amniotics AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 83.972%
Ziccum AB (publ) 857 Thousand SEK -201.05%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 48.182%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 89.464%
Genovis AB (publ.) 79.32 Million SEK 96.747%
Intervacc AB (publ) 181 Thousand SEK -1325.414%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 87.482%
Active Biotech AB (publ) 3 Million SEK 14.0%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 95.722%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 48.4%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 96.387%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 67.041%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -508.491%
Egetis Therapeutics AB (publ) 108.6 Million SEK 97.624%
Karolinska Development AB (publ) 3.07 Million SEK 15.961%
OncoZenge AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -158.0%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.737%
Camurus AB (publ) 24.5 Million SEK 89.472%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 90.641%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.702%
Cyxone AB (publ) 858 Thousand SEK -200.699%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK -50.789%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 92.991%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -287.387%
SynAct Pharma AB 637 Thousand SEK -305.024%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -203.529%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -46.508%
BioInvent International AB (publ) 23.24 Million SEK 88.9%
Alzinova AB (publ) 800 Thousand SEK -222.5%
Oncopeptides AB (publ) 106.48 Million SEK 97.577%
Pila Pharma AB (publ) 773.08 Thousand SEK -233.73%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 97.157%
Diamyd Medical AB (publ) 30.67 Million SEK 91.588%
Xbrane Biopharma AB (publ) 231.47 Million SEK 98.885%
Ascelia Pharma AB (publ) 1.06 Million SEK -143.167%
Diagonal Bio AB (publ) - SEK -Infinity%